Target intelligence / Profile preview

Vibrio cholerae lipopolysaccharide (V. cholerae LPS)

Target
V. cholerae LPS
Molecular classification
Other (Bacterial surface macromolecule), Other (Endotoxin), Other (Polysaccharide conjugate), Other (Microbial molecular pattern)
01

Overview

Vibrio cholerae lipopolysaccharide is a large, amphiphilic molecule found on the outer membrane surface of the Gram-negative bacterium Vibrio cholerae. LPS is composed of three main structural domains: lipid A (the hydrophobic anchor and toxic component), the core oligosaccharide, and the highly variable O-antigen polysaccharide chain, which determines serogroup specificity. The lipid A component can be modified (for example, by acylation changes) to enhance resistance to cationic antimicrobial peptides such as polymyxin B and to modulate immune detection. Variation in the O-antigen structure underpins the more than 200 serogroups of V. cholerae, with O1 and O139 being the most clinically important, causing epidemic cholera. The LPS molecule is critical for virulence through biofilm formation, intestinal adherence, and immune evasion, and it serves as a major antigen for diagnosis and vaccine development. LPS can also act as a receptor for bacteriophage infection and as an adhesin aiding bacterial colonization. The endotoxic activity of the lipid A portion contributes to the inflammatory response and sepsis risk during severe infections.

Other names
Vibrio cholerae LPSCholera lipopolysaccharideV. cholerae O-antigenVibrio cholerae endotoxin
02

Mechanism of action

Disruption of outer membrane by cationic peptides (e.g., polymyxin B binds to lipid A, causing membrane destabilization) Elicitation of host immune response as a pathogen-associated molecular pattern (PAMP)

03

Biological functions

Immune response activation, including endotoxic activityAntigenic determinant for serogroup classificationAdherence and biofilm formationPhage receptor activityResistance to antimicrobial peptidesStructural component of outer membrane
04

Disease associations

Infection (central to pathogenesis of cholera)Other (basis for serogrouping and epidemiological surveillance in cholera)
05

Safety considerations

Endotoxic shock (the lipid A moiety is responsible for host toxicity in severe gram-negative infections)Immune cross-reactivity (vaccine design must avoid unwanted immune responses)Structural variation among serogroups/strains may affect vaccine efficacy
06

Interacting drugs

Polymyxin B (antimicrobial peptide which interacts with LPS)

2 more in the full profile.

07

Biomarkers

O-antigen structure for V. cholerae serogroupingPresence in stool as an indicator of infection (diagnostic for cholera)

Beyond the preview

Go deeper on Vibrio cholerae lipopolysaccharide (V. cholerae LPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vibrio cholerae lipopolysaccharide (V. cholerae LPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call